- Supervisory Board appoints Tom Alzin and Jannick Hunecke
- Dr Rolf Scheffels to leave when his term of office ends
Frankfurt/Main, 27 November 2020. Changes are being made in the Board of Management at Deutsche Beteiligungs AG (DBAG): the Supervisory Board appointed two long-standing members of the investment team – Tom Alzin and Jannick Hunecke – as new members of the Board of Management. They will take up their new roles on 1 March 2021. Dr Rolf Scheffels will step down from the Board of Management at his own request, when his contract expires at the end of February 2021. He will remain associated with the company as a member of the Investment Advisory Committee of the most recently launched DBAG fund.
“For many years, Tom Alzin and Jannick Hunecke have been influential members of the investment team, with many years of management responsibility, and can both look back at a series of successful transactions”, Dr Hendrik Otto, Chairman of DBAG’s Supervisory Board, stated after yesterday’s board meeting. “I am delighted that by rejuvenating the Management Board through the appointment of our two colleagues we have been able to ensure continuity in the management of DBAG”, Dr Otto commented further.
Tom Alzin (born 1980) has worked as an investment manager for the listed private equity company since 2004; he became a Managing Director at Deutsche Beteiligungs AG at the end of 2011. After completing degrees in business administration, both he and Jannick Hunecke (born 1974) embarked upon their respective careers at DBAG: Jannick Hunecke started at the beginning of 2001 and became a Managing Director at the end of 2008. In recent years, both have made a significant contribution to the further development of DBAG, reflected in, for example, a broader market presence and strong growth in assets under advisory.
The Supervisory Board thanked Dr Scheffels for his many years of service to the company. “His work has not only produced numerous transactions with remarkable investment performance, but has also led to the continuous development of the processes and structures within the investment team”, Dr Otto said. Dr Scheffels (born 1966) joined Deutsche Beteiligungs AG at the start of 1997 and was appointed member of the Board of Management for the first time in 2004. He was responsible at that time for investment activity, and for managing relationships with investors in DBAG funds; he was also responsible for staff development within the investment team.
“Following an intensive career spanning three decades at DBAG, and previously with an auditing firm, I decided to hand over the reins of responsibility from next year onwards and not to seek renewal of my Board of Management term of office”, Dr Scheffels remarked; “We are in an excellent position with regard to personnel. With the youthful DBAG Fund VIII having got off to a very successful start with its first investments, now is the right time to hand over responsibility – also in the interests DBAG’s long-term development. I am delighted that I will continue to work together with my former colleagues, through my role in DBAG Fund VIII.”
DBAG’s Board of Management will be composed of four people in the future: Torsten Grede (born 1964) is the Spokesman of the Board of Management; his term of office runs until December 2023. Susanne Zeidler (born 1961) is the Chief Financial Officer; her tenure was extended recently until October 2025. Tom Alzin and Jannick Hunecke have each been appointed for five years.